WHO launched its Global Programme on AIDS
The FDA approved AZT as the first antiretroviral drug to be used as
a treatment for AIDS.
President Ronald Reagan and French Prime Minister Jacques Chirac announced
a joint agreement settling the dispute arising from the discovery
of the AIDS virus, the first international agreement relating to a
biomedical research issue to be announced by heads of state.
FDA approved the first Western blot blood test–a more specific
HIV diagnostic test.
The CDC reported that between 1981 and 1987, nine health care workers
caring for AIDS patients and having no other risk factors had been
infected with HIV.
NHLBI awarded a contract to maintain a colony of 50 chimpanzees for
studies of post-transfusion HIV infection and AIDS.
The CDC reported 40,051 cases of AIDS in the United States with 23,165
The CDC revised its definition of AIDS to place a greater emphasis
on HIV infection status.
On August 18, Dr. H. Clifford Lane and his NIAID colleagues began
the first U.S. clinical trial at NIH to test an experimental HIV vaccine
NIAID established the AIDS Vaccine Evaluation Group (AVEG), a network
of clinical sites to conduct trials of experimental HIV vaccines.
The NIH Office of the Director launched its Targeted Antiviral Program
to encourage intramural analysis of the three-dimensional structure
of HIV and to determine the shape of protein-bound drugs.
Cleve Jones made the first panel for the AIDS Memorial Quilt in memory
of his friend Marvin Feldman.
NIAID established 17 Clinical Study Groups (CSGs) to extend to a wider
geographical area access to clinical trials of promising AIDS therapies.
The CDC released the results of a study on the prevalence of HIV infection
in the United States, indicating a shifting emphasis toward defining
AIDS as “infection with HIV” rather than by defining particular
“indicator diseases” that characterized late-stage AIDS.